Suppr超能文献

地中海贫血综合征中的脑血管损伤:一个新出现的挑战。

Vascular Brain Damage in Thalassemia Syndrome: An Emerging Challenge.

作者信息

Hashemieh Mozhgan, Jafari Narjes

机构信息

Pediatric hematologist and oncologist Imam Hossein Medical Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

Pediatric Neurologist Imam Hossein Medical Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

出版信息

Iran J Child Neurol. 2022 Winter;16(1):19-29. doi: 10.22037/ijcn.v16i3.33794. Epub 2022 Jan 1.

Abstract

Thalassemia syndromes are the most prevalent monogenic hemoglobinopathy in the world. In Iran, thalassemia is a public health problem because this country has been located on the thalassemia belt. In recent decades, considering that the life expectancy of patients with thalassemia has dramatically improved, some unrecognized complications have emerged in these individuals. One of these complications is a hypercoagulable state that may lead to thromboembolic events (TEE). The TEE may involve any organ in the body, including the central nervous system. Ischemic cerebrovascular events in thalassemic patients have been divided into two categories, namely overt stroke and silent cerebral infarcts (SCI). Overt stroke often develops in patients with beta-thalassemia major; however, patients with thalassemia intermedia usually suffer from SCI. This review article discusses brain vascular involvement.

摘要

地中海贫血综合征是世界上最常见的单基因血红蛋白病。在伊朗,地中海贫血是一个公共卫生问题,因为该国位于地中海贫血带上。近几十年来,鉴于地中海贫血患者的预期寿命显著提高,这些个体出现了一些未被认识到的并发症。其中一种并发症是高凝状态,可能导致血栓栓塞事件(TEE)。TEE可能累及身体的任何器官,包括中枢神经系统。地中海贫血患者的缺血性脑血管事件分为两类,即显性卒中与无症状脑梗死(SCI)。显性卒中常发生于重型β地中海贫血患者;然而,中间型地中海贫血患者通常患有SCI。这篇综述文章讨论了脑血管受累情况。

相似文献

1
Vascular Brain Damage in Thalassemia Syndrome: An Emerging Challenge.
Iran J Child Neurol. 2022 Winter;16(1):19-29. doi: 10.22037/ijcn.v16i3.33794. Epub 2022 Jan 1.
2
Cerebral thrombosis in patients with β-thalassemia: a systematic review.
Blood Coagul Fibrinolysis. 2012 Apr;23(3):212-7. doi: 10.1097/MBC.0b013e3283502975.
3
Thrombosis in thalassemia: why are we so concerned?
Hemoglobin. 2011;35(5-6):503-10. doi: 10.3109/03630269.2011.605499. Epub 2011 Sep 12.
4
The hypercoagulable state in thalassemia.
Blood. 2002 Jan 1;99(1):36-43. doi: 10.1182/blood.v99.1.36.
5
The hypercoagulable state in thalassemia intermedia.
Hemoglobin. 2009;33 Suppl 1:S160-9. doi: 10.3109/03630260903351619.
7
Redefining thalassemia as a hypercoagulable state.
Ann N Y Acad Sci. 2010 Aug;1202:231-6. doi: 10.1111/j.1749-6632.2010.05548.x.
8
Thalassemia and hypercoagulability.
Blood Rev. 2008 Sep;22(5):283-92. doi: 10.1016/j.blre.2008.04.001. Epub 2008 Jun 3.
9
Hypercoagulability in β-thalassemia: a status quo.
Expert Rev Hematol. 2012 Oct;5(5):505-11; quiz 512. doi: 10.1586/ehm.12.42.
10
Circulating microparticles and the risk of thromboembolic events in Egyptian beta thalassemia patients.
Ann Hematol. 2017 Apr;96(4):597-603. doi: 10.1007/s00277-017-2925-x. Epub 2017 Feb 7.

引用本文的文献

1
Clinical Image-Vertebral artery beading in a child with Beta Thalassemia major.
Oxf Med Case Reports. 2025 May 28;2025(5):omaf023. doi: 10.1093/omcr/omaf023. eCollection 2025 May.
2
Pipeline embolization in patients with hemoglobinopathies: A cohort study.
Interv Neuroradiol. 2025 May 13:15910199251339550. doi: 10.1177/15910199251339550.
3
Comparison of Asymptomatic Brain Lesions Between Thalassemia Major and Sickle Cell Anemia Patients.
Medicina (Kaunas). 2025 Jan 19;61(1):159. doi: 10.3390/medicina61010159.

本文引用的文献

1
Frequency of silent brain lesions and aspirin protection evaluation over 3 years follow-up in beta thalassemia patients.
Ann Hematol. 2019 Oct;98(10):2267-2271. doi: 10.1007/s00277-019-03765-0. Epub 2019 Aug 6.
2
Hypercoagulability and Vascular Disease.
Hematol Oncol Clin North Am. 2018 Apr;32(2):237-245. doi: 10.1016/j.hoc.2017.11.001. Epub 2017 Dec 1.
3
β-Thalassemia intermedia: a comprehensive overview and novel approaches.
Int J Hematol. 2018 Jul;108(1):5-21. doi: 10.1007/s12185-018-2411-9. Epub 2018 Jan 29.
4
Non-Transfusion-Dependent Thalassemia: An Update on Complications and Management.
Int J Mol Sci. 2018 Jan 8;19(1):182. doi: 10.3390/ijms19010182.
6
Rivaroxaban Use in Patients with Hemoglobinopathies.
Hemoglobin. 2017 May;41(3):223-224. doi: 10.1080/03630269.2017.1374969.
7
Coagulation defects in thalassemic patients.
Pediatr Neonatol. 2017 Oct;58(5):421-424. doi: 10.1016/j.pedneo.2016.07.009. Epub 2017 Feb 17.
8
Safety profile of the direct oral anticoagulants: an analysis of the WHO database of adverse drug reactions.
Br J Clin Pharmacol. 2017 Jul;83(7):1532-1543. doi: 10.1111/bcp.13234. Epub 2017 Mar 19.
9
High incidence of silent cerebral infarcts in adult patients with beta thalassemia major.
Thromb Res. 2016 Aug;144:119-22. doi: 10.1016/j.thromres.2016.06.010. Epub 2016 Jun 14.
10
Rivaroxaban induced liver injury: A cholestatic pattern.
Int J Cardiol. 2016 Aug 1;216:97-8. doi: 10.1016/j.ijcard.2016.04.063. Epub 2016 Apr 13.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验